Home » Newsletters » BioWorld Science

BioWorld Science

April 13, 2015

View Archived Issues

DS-107 cream as a promising new treatment for atopic dermatitis

LXRbeta partial agonist shows potential for the treatment of atherosclerosis

Researchers report CTNNB1 mutations in NMC and NMC-Fi for the first time

Ipsen and Hannover Medical School to research recombinant botulinum neurotoxins

Max Planck Society presents synthetic pneumococcal vaccines

DiscoveryBioMed receives NIH grant to discover adiponectin secretion stimulators

Investigators report presence of CD117 in Leydig cell tumors

Pharmakea divulges autotaxin inhibitors

Frizzled receptor antagonist attenuates adverse remodeling

Pfizer establishes grants program to advance PCSK9 research

Nurelin receives orphan drug designation in U.S.

Viral nanoparticle product AU-011 granted orphan drug status in U.S.

Actimmune receives FDA fast track designation for the treatment of Friedreich's ataxia

FDA modifies partial clinical hold on Tekmira's TKM-Ebola IND

oxLDL-induced apoptotic dendritic cells show efficacy as a potential therapy for atherosclerosis

Celgene invests in Mesoblast and gains option to license cancer and inflammation cell therapies

ReNeuron files IND to begin U.S. phase I/II study candidate for retinitis pigmentosa

Medivir and Cancer Research Technology collaborate to develop ADAM8 inhibitors

Calitor Sciences discloses new PI3K inhibitors

Bristol-Myers Squibb patents RORgamma modulators

Vernalis presents PDK inhibitors

Eisai and Arena complete registrational studies of extended-release lorcaserin

Lilly Chk1 inhibitor granted U.S. orphan drug status for anal cancer

Merck & Co.'s grazoprevir/elbasvir gains BTDs from FDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...